Please assess the completion status of the following clinical trial:

Trial Title: Proper Fractional Flow Reserve Criteria for Intermediate Lesions in the Era of Drug-eluting Stent

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Elective PCI~* Angiographically intermediate stenosis (50-75% by visual estimation) in native major coronary arteries, proximal and mid (branch, distal lesion: exclusion)~* Reference diameter \> 2.5mm, lesion length \< 60mm (cover by 2 stents)~* No documented evidence of ischemia by noninvasive tests~Exclusion Criteria:~* Acute ST elevation MI~* Left main disease~* Chronic renal failure (cr \>2 mg/dL)~* Expected survival \< 2yrs~* \> 1degree AV block

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: OTHER): Fractional flow guided drug-eluting stent implantation arm
- 2 (Type: OTHER): Routine drug-eluting stent implantation

Based on this trial design, predict the completion outcome and termination type (if applicable).